← Eichor
Study identifier: NCT07527143 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Condition: Endometrial Carcinoma  ·  Sponsor: Mayo Clinic

PhaseN/A
Planned participants25
Who can joinFemale, 45 Years to no upper limit
Healthy volunteersYes

About this study

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Trials Referral Office  ·  855-776-0015  ·  mayocliniccancerstudies@mayo.edu

Kelly Gunderson  ·  507-422-1892

Always discuss trial participation with your own doctor first.

Locations (1)

Mayo Clinic in RochesterRochester, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07527143